Abstract
Recent genome-wide association studies have identified MAD1L1 (mitotic arrest deficient-like 1) as a susceptibility gene for bipolar disorder and schizophrenia. The minor allele of the single-nucleotide polymorphism (SNP) rs11764590 in MAD1L1 was associated with bipolar disorder. Both diseases, bipolar disorder and schizophrenia, are linked to functional alterations in the reward system. We aimed at investigating possible effects of the MAD1L1 rs11764590 risk allele on reward systems functioning in healthy adults. A large homogenous sample of 224 young (aged 18–31 years) participants was genotyped and underwent functional magnetic resonance imaging (fMRI). All participants performed the ‘Desire-Reason Dilemma’ paradigm investigating the neural correlates that underlie reward processing and active reward dismissal in favor of a long-term goal. We found significant hypoactivations of the ventral tegmental area (VTA), the bilateral striatum and bilateral frontal and parietal cortices in response to conditioned reward stimuli in the risk allele carriers compared with major allele carriers. In the dilemma situation, functional connectivity between prefrontal brain regions and the ventral striatum was significantly diminished in the risk allele carriers. Healthy risk allele carriers showed a significant deficit of their bottom-up response to conditioned reward stimuli in the bilateral VTA and striatum. Furthermore, functional connectivity between the ventral striatum and prefrontal areas exerting top-down control on the mesolimbic reward system was reduced in this group. Similar alterations in reward processing and disturbances of prefrontal control mechanisms on mesolimbic brain circuits have also been reported in bipolar disorder and schizophrenia. Together, these findings suggest the existence of an intermediate phenotype associated with MAD1L1.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Abler B, Greenhouse I, Ongur D, Walter H, Heckers S (2008). Abnormal reward system activation in mania. Neuropsychopharmacology 33: 2217–2227.
Bergen SE, O’Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al (2012). Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 17: 880–886.
Bogdan R, Nikolova YS, Pizzagalli DA (2013). Neurogenetics of depression: a focus on reward processing and stress sensitivity. Neurobiol Dis 52: 12–23.
Brett M, Anton J-L, Valabregue R, Poline J-B (2002). Region of interest analysis using the MarsBar toolbox for SPM 99. NeuroImage 16: S497.
Calhoun VD, Sui J, Kiehl K, Turner J, Allen E, Pearlson G (2011). Exploring the psychosis functional connectome: aberrant intrinsic networks in schizophrenia and bipolar disorder. Front Psychiatry 2: 75.
Cardno AG, Owen MJ (2014). Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder. Schizophr Bull 40: 504–515.
Caseras X, Lawrence NS, Murphy K, Wise RG, Phillips ML (2013). Ventral striatum activity in response to reward: differences between bipolar I and II disorders. Am J Psychiatry 170: 533–541.
Chai XJ, Whitfield-Gabrieli S, Shinn AK, Gabrieli JDE, Nieto Castañón A, McCarthy JM et al (2011). Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology 36: 2009–2017.
Cichon S, Mühleisen TW, Degenhardt FA, Mattheisen M, Miró X, Strohmaier J et al (2011). Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 88: 372–381.
Cloninger CR, Bayon C, Svrakic DM (1998). Measurement of temperament and character in mood disorders: a model of fundamental states as personality types. J Affect Disord 51: 21–32.
Cloninger C, Svrakic DM, Przybeck TR (1993). A psychobiological model of temperament and character. Arch Gen Psychiatry 50: 975–990.
Deserno L, Boehme R, Heinz A, Schlagenhauf F (2013). Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Front Psychiatry 4: 172.
Diekhof EK, Gruber O (2010). When desire collides with reason: functional interactions between anteroventral prefrontal cortex and nucleus accumbens underlie the human ability to resist impulsive desires. J Neurosci 30: 1488–1493.
Diekhof EK, Keil M, Obst KU, Henseler I, Dechent P, Falkai P et al (2012). A functional neuroimaging study assessing gender differences in the neural mechanisms underlying the ability to resist impulsive desires. Brain Res 1473: 63–77.
Fresán A, León-Ortiz P, Robles-García R, Azcárraga M, Guizar D, Reyes-Madrigal F et al (2015). Personality features in ultra-high risk for psychosis: a comparative study with schizophrenia and control subjects using the Temperament and Character Inventory-Revised (TCI-R). J Psychiatr Res 61: 168–173.
Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ (1997). Psychophysiological and modulatory interactions in neuroimaging. NeuroImage 6: 218–229.
Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636–645.
Gradin VB, Kumar P, Waiter G, Ahearn T, Stickle C, Milders M et al (2011). Expected value and prediction error abnormalities in depression and schizophrenia. Brain J Neurol 134: 1751–1764.
Gradin VB, Waiter G, O’Connor A, Romaniuk L, Stickle C, Matthews K et al (2013). Salience network-midbrain dysconnectivity and blunted reward signals in schizophrenia. Psychiatry Res 211: 104–111.
Grimm O, Heinz A, Walter H, Kirsch P, Erk S, Haddad L et al (2014). Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia. JAMA Psychiatry 71: 531–539.
Hall GBC, Milne AMB, Macqueen GM (2014). An fMRI study of reward circuitry in patients with minimal or extensive history of major depression. Eur Arch Psychiatry Clin Neurosci 264: 187–198.
Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA et al (2012). An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489: 391–399.
Hill MJ, Donocik JG, Nuamah RA, Mein CA, Sainz-Fuertes R, Bray NJ (2014). Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells. Schizophr Res 153: 225–230.
Jetha MK, Goldberg JO, Schmidt LA (2013). Temperament and its relation to social functioning in schizophrenia. Int J Soc Psychiatry 59: 254–263.
Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A et al (2006). Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) 187: 222–228.
Kapur S (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13–23.
Keedwell PA, Andrew C, Williams SCR, Brammer MJ, Phillips ML (2005). The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 58: 843–853.
Kemner SM, Mesman E, Nolen WA, Eijckemans MJC, Hillegers MHJ (2015). The role of life events and psychological factors in the onset of first and recurrent mood episodes in bipolar offspring: results from the Dutch Bipolar Offspring Study. Psychol Med 45: 2571–2581.
Kirschner M, Hager OM, Bischof M, Hartmann MN, Kluge A, Seifritz E et al (2015). Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia. J Psychiatry Neurosci 40: 140383.
Knutson B, Fong GW, Adams CM, Varner JL, Hommer D (2001). Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 12: 3683–3687.
Lake RJ, Boetefuer EL, Tsai P-F, Jeong J, Choi I, Won K-J et al (2014). The sequence-specific transcription factor c-Jun targets Cockayne syndrome protein B to regulate transcription and chromatin structure. PLoS Genet 10: e1004284.
Mason L, O’Sullivan N, Montaldi D, Bentall RP, El-Deredy W (2014). Decision-making and trait impulsivity in bipolar disorder are associated with reduced prefrontal regulation of striatal reward valuation. Brain J Neurol 137: 2346–2355.
Nitzburg GC, Malhotra AK, DeRosse P (2014). The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults. Eur Psychiatry 29: 352–357.
Nusslock R, Almeida JR, Forbes EE, Versace A, Frank E, Labarbara EJ et al (2012). Waiting to win: elevated striatal and orbitofrontal cortical activity during reward anticipation in euthymic bipolar disorder adults. Bipolar Disord 14: 249–260.
Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Iwase M et al (2012). Personality traits and schizophrenia: evidence from a case-control study and meta-analysis. Psychiatry Res 198: 7–11.
O’Sullivan N, Szczepanowski R, El-Deredy W, Mason L, Bentall RP (2011). fMRI evidence of a relationship between hypomania and both increased goal-sensitivity and positive outcome-expectancy bias. Neuropsychologia 49: 2825–2835.
Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51: 768–774.
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.
Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011). Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43: 977–983.
Redlich R, Dohm K, Grotegerd D, Opel N, Zwitserlood P, Heindel W et al (2015). Reward processing in unipolar and bipolar depression: a functional MRI study. Neuropsychopharmacology 40: 2623–2631.
Rodriguez S, Gaunt TR, Day INM (2009). Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169: 505–514.
Rosenström T, Jylhä P, Robert Cloninger C, Hintsanen M, Elovainio M, Mantere O et al (2014). Temperament and character traits predict future burden of depression. J Affect Disord 158: 139–147.
Ruderfer DM, Fanous AH, Ripke S, McQuillin A, Amdur RL et al Schizophrenia Working Group of Psychiatric Genomics Consortium (2014). Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 19: 1017–1024.
Satterthwaite TD, Kable JW, Vandekar L, Katchmar N, Bassett DS, Baldassano CF et al (2015). Common and dissociable dysfunction of the reward system in bipolar and unipolar depression. Neuropsychopharmacology 40: 2258–2268.
Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011). Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969–976.
Strakowski SM, Fleck DE, DelBello MP, Adler CM, Shear PK, Kotwal R et al (2010). Impulsivity across the course of bipolar disorder. Bipolar Disord 12: 285–297.
Subramaniam K, Hooker CI, Biagianti B, Fisher M, Nagarajan S, Vinogradov S (2015). Neural signal during immediate reward anticipation in schizophrenia: Relationship to real-world motivation and function. NeuroImage Clin 9: 153–163.
Sun Q, Zhang X, Liu T, Liu X, Geng J, He X et al (2013). Increased expression of mitotic arrest deficient-like 1 (MAD1L1) is associated with poor prognosis and insensitive to Taxol treatment in breast cancer. Breast Cancer Res Treat 140: 323–330.
Tamminga CA, Ivleva EI, Keshavan MS, Pearlson GD, Clementz BA, Witte B et al (2013). Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 170: 1263–1274.
Trost S, Diekhof EK, Zvonik K, Lewandowski M, Usher J, Keil M et al (2014). Disturbed anterior prefrontal control of the mesolimbic reward system and increased impulsivity in bipolar disorder. Neuropsychopharmacology 39: 1914–1923.
Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata H, Fujimoto T et al (2001). Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 20: 3301–3305.
Vessoni AT, Herai RH, Karpiak JV, Leal AMS, Trujillo CA, Quinet A et al (2016). Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony. Hum Mol Genet 25: 1271–1280.
Waltz JA, Schweitzer JB, Gold JM, Kurup PK, Ross TJ, Salmeron BJ et al (2009). Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology 34: 1567–1577.
Whalley HC, Papmeyer M, Sprooten E, Lawrie SM, Sussmann JE, McIntosh AM (2012). Review of functional magnetic resonance imaging studies comparing bipolar disorder and schizophrenia. Bipolar Disord 14: 411–431.
Whitton AE, Treadway MT, Pizzagalli DA (2015). Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Curr Opin Psychiatry 28: 7–12.
Yip SW, Worhunsky PD, Rogers RD, Goodwin GM (2015). Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder. Neuropsychopharmacology 40: 658–666.
Zaninotto L, Souery D, Calati R, Di Nicola M, Montgomery S, Kasper S et al (2015). Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression. J Affect Disord 184: 51–59.
Zhang X, Huang S, Zhang Z, Wang W (2012). Chapter 10: Mining genome-wide genetic markers. PLoS Comput Biol 8: e1002828.
Acknowledgements
We thank Dr Sergi Papiol for his helpful support with regard to the genetic sample.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Trost, S., Diekhof, E., Mohr, H. et al. Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System. Neuropsychopharmacol 41, 2679–2687 (2016). https://doi.org/10.1038/npp.2016.70
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2016.70
This article is cited by
-
DNA methylation as a potential mediator of the association between prenatal tobacco and alcohol exposure and child neurodevelopment in a South African birth cohort
Translational Psychiatry (2022)
-
MAD1L1 and TSNARE gene polymorphisms are associated with schizophrenia susceptibility in the Han Chinese population
BMC Medical Genomics (2021)
-
Towards precision medicine for stress disorders: diagnostic biomarkers and targeted drugs
Molecular Psychiatry (2020)
-
Identifying common genome-wide risk genes for major psychiatric traits
Human Genetics (2020)
-
Subjective responses to amphetamine in young adults with previous mood elevation experiences
Psychopharmacology (2019)
